GZMB and hepatocellular carcinoma: In vivo, ICT treatment notably enhanced the expression of cleaved-caspase1, cleaved-caspase3, and granzyme B, modulated cytokine secretion, and stimulated immune cell infiltration, leading to tumor growth suppression in HCC mice.